2 results match your criteria: "National Naval Medical Center and Uniformed Services University of Health Sciences[Affiliation]"
Arch Dermatol
March 2010
National Naval Medical Center and Uniformed Services University of Health Sciences, Bethesda, Maryland, USA.
Mayo Clin Proc
October 1997
Navy Medical Oncology Branch, National Naval Medical Center and Uniformed Services University of Health Sciences, Bethesda, Maryland 20889-5105, USA.
Objective: To determine the outcome of all patients with small-cell lung cancer (SCLC) treated at the US National Cancer Institute between April 1973 and April 1993.
Design: We retrospectively analyzed a series of 594 consecutive patients with SCLC treated at a single institution during a 20-year period to assess changes in duration of survival and toxicity related to various treatment regimens.
Material And Methods: For analysis, patients were grouped by decade, and the duration of survival of patients with limited- and extensive-stage SCLC was examined to assess whether patients treated during the first decade of the study (1973 through 1983), when cyclophosphamide-based regimens were used, had different outcomes than those treated during the second decade (1983 through 1993), when cisplatin-based regimens were used.